'Nanobodies' from alpacas could help bring CAR T-cell therapy to solid tumors

In 1989, two undergraduate students at the Free University of Brussels were asked to test frozen blood serum from camels, and stumbled on a previously unknown kind of antibody. It was a miniaturized version of a human antibody, made up only of two heavy protein chains, rather than two light and two heavy chains. As they eventually reported, the antibodies' presence was confirmed not only in camels, but also in llamas and alpacas.

from Nanotechnology News - Nanoscience, Nanotechnolgy, Nanotech News http://bit.ly/2KtRZnE